Syapse, a healthcare data analytics company that helps health systems crunch and analyze genomics data and clinical data to support treatment decisions has closed a Series B round. It will go toward expanding the company’s sales and marketing muscle and advance clinical development. Safeguard Scientifics led the $10 million Series B round, and […]
Dr. Amy Abernethy, a medical oncologist from Duke University School of Medicine who has championed clinical informatics and working with patients to develop more personalized cancer care, has joined Flatiron Health.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Cleveland biotech company Western Oncolytics is developing an immune-oncolytic therapy licensed by the University of Pittsburgh which combines oncolytic virus and gene therapy technologies to rid cancer cells of the ability to survive in the body. According to their website, the company expects their technology to extend the lives of, or even cure, patients with an array of […]
A biotechnology startup that spun out of University Hospitals of Cleveland last year has raised its first big round of financing since its launch two years ago. Dual Therapeutics, which is developing therapeutics for prostate cancer, lung cancer and acute lymphoblastic leukemia, is raising $7.5 million, according to an amended Form D filed with the […]
Some cancer patients and their insurers are seeing their bills for chemotherapy jump sharply, reflecting increased drug prices and hospitals’ push to buy oncologists’ practices and then bill at higher rates. Patients say, “‘I’ve been treated with Herceptin for breast cancer for several years and it was always $5,000 for the drug and suddenly it’s […]
With a little genetic engineering, the vaccine that was key in helping eradicate smallpox more than 30 years ago could also be key in curing cancer, if a young Cleveland biotech has anything to say about it. Western Oncolytics is developing a dual-mechanism therapy that combines oncolytic virus and gene therapy technologies with the hope […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Car makers aren’t the only ones adapting breathalyzer technology to improve health and safety. A group of researchers from University of Vermont is developing a way to apply the technology to detect bacterial infections in the lungs, such as TB. But researchers with Cleveland Clinic’s Respiratory Institute are working on a breath test for cancer […]
Update below Oncology analytics company Flatiron Health is part of a healthcare industry trend to de-silo and aggregate cancer data to help physicians and patients make more informed decisions about treatment. It has completed a $130 million series B round led by Google Ventures — its largest medical software investment to date, according to The […]
Even as global sales for oncology drugs topped $91 billion last year, a new report suggests a combination of factors is having an impact on cancer treatment. More targeted therapies treating smaller patient populations, reimbursement, rising drug costs and more effective screening and behavior change will impact treatment in the future, according to a report […]
Everyone likes to talk about funding for digital health – Y Combinator is doing biotech now! Andreesen Horowitz gets into health tech! Deals and dollars look great in Q1 2014! It’s not as easy to make cheery slide decks about funding for the rest of the healthcare startup world: pharma, medical devices and bio tech […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Pfizer’s $100 billion acquisition pitch for AstraZeneca took an interesting turn this week with both companies (AstraZeneca and Pfizer) clarifying their positions in detail for the first time. The companies’ continuing dialogue follows a week in which GlaxoSmithKline and Novartis made a series of targeted deals designed to streamline their businesses, but also build on […]
Underscoring the hot investment prospects of cancer immunotherapy, Juno Therapeutics has secured additional funding from investors to close its Series A at $176 million, according to a company statement. The company is developing two immunotherapy platforms to treat hematologic and solid tumor cancers and reduce the toxicity associated with chemotherapeutics. The completion of the A […]
Update below It’s all change with Big Pharma this week. A series of deals between GlaxoSmithKline (NYSE: GSK) and Novartis has reshaped both businesses in a move that will shift GSK away from the cancer drug development business and boost its vaccine business. A statement from GSK offered some highlights: GSK is scaling back high-risk […]
Here’s another addition to the list of potential health applications for Oculus Rift. Last fall video game artist Pri Firstenberg got ahold of an early version of the virtual reality headset for her grandmother, who was dying from cancer and unable to leave home. She filmed the above video of her grandmother, Roberta, trying some […]
Cancer drug developer ProNAi Therapeutics, which developed a nucleic acid-based DNA-interference technology to cause cancer cell death, has added nine new investors in an oversubscribed Series D round. The latest fundraise will help support Phase 2 clinical trials for its recurrent non-Hodgkin lymphoma treatment, follicular lymphoma, Richter’s transformation and large B-cell lymphoma, according to a […]